McDermott Will & Emery represented Young Innovations, Inc. (NASDAQ: YDNT) in connection with the completion of its sale to an affiliate of Linden Capital Partners, a Chicago-based private equity firm, in an all-cash transaction valued at approximately $314 million. The transaction closed on January 31, 2013.
Pursuant to the Merger Agreement, which was approved by Young Innovations shareholders on January 30, 2013, holders of outstanding shares of common stock of Young Innovations received $39.50 per share, representing a 12.5 percent premium to the 30-day average closing stock price. With the completion of the acquisition, Young Innovations is now a private company.
Young Innovations is a leading U.S. manufacturer and distributor of supplies and equipment used by dentists, dental hygienists, dental assistants and consumers.
“Young Innovations has been a valued client for over 14 years,” said Corporate partner John Tamisiea who led the McDermott team. “We are enormously pleased to have assisted this dynamic company as it grew and expanded into an industry leader, culminating in an acquisition that delivered significant value to shareholders.”
In addition to Mr. Tamisiea, the McDermott transaction team included partners Samuel Wales, John Hammond, Daniel Zucker, James Cohen, Joseph Paquin, Jennifer Mikulina, Ruth Wimer, Maureen O’Brien, Carla Hine and Mark Bilut, as well as associates Brian Singer, Mathew Rupp, Ulrika Mattsson and Joseph Urwitz.
McDermott’s mergers and acquisitions (M&A) practice provides clients sophisticated, legal counsel for both domestic and cross-border transactions. Our lawyers advise U.S. and multinational corporations, private equity funds, emerging companies and venture-funded start ups on the full range of M&A needs involving publicly traded and privately owned companies.
